Valeritas launches V-Go insulin delivery device in New Zealand

This article was originally published here

Valeritas (NSDQ:VLRX) said today that its V-Go wearable insulin delivery device is now available in New Zealand thanks to an exclusive distribution deal with NZMS Diabetes.

According to the terms of the agreement, Valeritas will be responsible for product development, regulatory approval, manufacturing and quality management while NZMS Diabetes will take over the sales, marketing, customer support and distribution responsibilities in New Zealand.

Get the full story at our sister site, Drug Delivery Business News.

The post Valeritas launches V-Go insulin delivery device in New Zealand appeared first on MassDevice.

0 replies

Leave a Reply

Want to join the discussion?
Feel free to contribute!

Leave a Reply